[A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
Toshinori Sueda(The University of Osaka), Osamu Ishikawa(Gunma University), Masahiko Yano(Nagoya Sangyo University), Masaaki Motoori(Osaka International Cancer Institute), Masayuki Ohue(Hyogo Medical University), Hiroaki Ohigashi(Teine Keijinkai Hospital), Hidenori Takahashi(Osaka International Cancer Institute), Kentaro Kishi(Osaka International Cancer Institute), Kunihito Gotoh(Osaka International Cancer Institute), Yasuhiko Tomita(Osaka International Cancer Institute), Yoshiyuki Fujiwara(Osaka International Cancer Institute), Tatsushi Shingai(Kinki Central Hospital), Shingo Noura(Osaka Rosai Hospital), Shigeru Marubashi(Osaka International Cancer Institute)
PubMed
November 1, 2013
Cited by 0
Related Papers
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Practical Usefulness of Lymphatic and Connective Tissue Clearance for the Carcinoma of the Pancreas Head
|Annals of Surgery|1988|373
Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice.
|PubMed|2000|334
Application of sentinel node biopsy to gastric cancer surgery
|Surgery|2001|268